In-vitro Diagnostic Services Market, Global Outlook and Forecast 2023-2029

In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a personﾒs overall health to help cure, treat, or prevent diseases.

In vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next generation sequencing tests, which scan a personﾒs DNA to detect genomic variations.

Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
This report aims to provide a comprehensive presentation of the global market for In-vitro Diagnostic Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-vitro Diagnostic Services. This report contains market size and forecasts of In-vitro Diagnostic Services in global, including the following market information:
Global In-vitro Diagnostic Services Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global In-vitro Diagnostic Services market was valued at US$ 66330 million in 2022 and is projected to reach US$ 88020 million by 2029, at a CAGR of 4.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Infectious Testing Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of In-vitro Diagnostic Services include BioRad, DexCom, Nova Biomedical, OraSure, Pearl Pathways, Phenomenex, Qiagen, Roche Diagnostics and Siemens, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the In-vitro Diagnostic Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global In-vitro Diagnostic Services Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global In-vitro Diagnostic Services Market Segment Percentages, by Type, 2022 (%)
    Infectious Testing
    Diabetes Testing
    Molecular Testing
    Tissue Testing
Global In-vitro Diagnostic Services Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global In-vitro Diagnostic Services Market Segment Percentages, by Application, 2022 (%)
    Hospitals
    Point-Of-Care Testing
    Laboratories
    Academic Institutes
Global In-vitro Diagnostic Services Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global In-vitro Diagnostic Services Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies In-vitro Diagnostic Services revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies In-vitro Diagnostic Services revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    BioRad
    DexCom
    Nova Biomedical
    OraSure
    Pearl Pathways
    Phenomenex
    Qiagen
    Roche Diagnostics
    Siemens
    Sysmex
    Thermofisher
Outline of Major Chapters:
Chapter 1: Introduces the definition of In-vitro Diagnostic Services, market overview.
Chapter 2: Global In-vitro Diagnostic Services market size in revenue.
Chapter 3: Detailed analysis of In-vitro Diagnostic Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of In-vitro Diagnostic Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.